Showing results (161-170 of 208) with videos related to
Sort By:
Pageof 21
Cancer|April 14, 2026
A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancerKathy D Miller, Alexandra Thomas, Sandra Althouse, et al.Scientific Reports|July 31, 2012
Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistanceJames W Antoon, Rongye Lai, Amanda P Struckhoff, et al.Cancer Research|May 31, 2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cellsM Danielle Bareford, Margaret A Park, Adly Yacoub, et al.Cancer Research|January 19, 2012
KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1ABu-Nam Jeon, Min-Kyeong Kim, Won-Il Choi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizerFang Fang, Joanne Munck, Jessica Tang, et al.Oncoscience|May 24, 2021
Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancerMargarite D Matossian, Van T Hoang, Hope E Burks, et al.Molecular Carcinogenesis|October 21, 2014
Elevated expression of long intergenic non-coding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cellsYan Zhuang, Hong T Nguyen, Matthew E Burow, et al.Molecular Cancer Therapeutics|May 12, 2012
Growth inhibition of ovarian tumor-initiating cells by niclosamideYi-Te Yo, Ya-Wen Lin, Yu-Chi Wang, et al.Cancer Research|March 15, 2008
Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylomeAlfred S L Cheng, Aedín C Culhane, Michael W Y Chan, et al.Cancer Research|September 9, 2011
Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancerChunpeng Zhang, Liguo Wang, Dayong Wu, et al.Pageof 21